Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes

NCT03011021 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Type1 Diabetes Mellitus
Autoimmune Diabetes

Interventions

DRUG: Liraglutide
BIOLOGICAL: UCB-Treg
DRUG: Insulin

Sponsor

Second Xiangya Hospital of Central South University